【摘要】：隨著規(guī)范產(chǎn)前檢查的不斷開展,宮頸細(xì)胞學(xué)檢查的逐漸推廣,越來越多的宮頸癌和宮頸病變在妊娠期被發(fā)現(xiàn),目前研究表明:宮頸癌的"三階梯"診斷方法同樣適用于妊娠期宮頸癌的診斷,且臨床分期與非妊娠期宮頸癌相同。目前對妊娠期宮頸癌的治療尚無統(tǒng)一標(biāo)準(zhǔn),手術(shù)方式、時(shí)機(jī)、化療藥物的選擇、劑量和療程以及分娩方式尚需進(jìn)一步研究。對于ⅠA期、ⅠB1期及腫瘤直徑≤2 cm、ⅠB1期及腫瘤直徑2 cm以及更高分期的患者,可采取個(gè)體化的治療方案。臨床醫(yī)師需在充分評估患者情況后,盡量保護(hù)患者和胎兒的利益,爭取達(dá)到控制疾病、保障患者及其生育能力并盡量保留胎兒的治療目的。
[Abstract]:With the continuous development of standard antenatal examination and the gradual popularization of cervical cytology, more and more cervical cancer and cervical lesions are discovered during pregnancy. Current studies show that the "three-step" diagnostic method for cervical cancer is also applicable to the diagnosis of cervical cancer in pregnancy, and its clinical staging is the same as that in non-pregnancy cervical cancer. At present, there is no uniform standard for the treatment of cervical cancer complicating pregnancy. The operation method, timing, choice of chemotherapy drugs, dosage and course of treatment, and delivery mode need further study. For patients with stage 鈪，

本文編號：2130524